Algen Biotechnologies
PrivateLast Round
Seed
Aug 31, 2021
Total Funding Raised
$5.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Algen Biotechnologies is a biotechnology company that has developed a platform for therapeutics and drug discovery using CRISPR and AI to find treatments for cancer, inflammation and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Algen Biotechnologies Comparables
Compare Algen Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CoSyne Therapeutics | 83% | |
| Insitro | 83% | |
| Transcripta Bio | 81% |
Algen Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 31, 2021 |
Algen Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cota Capital | Seed |
| Sequoia Capital | Seed |
| Viking Global Investors | Seed |
| Draper Associates | Seed |
| Y Combinator | Seed |
| LifeSpan Vision Ventures | Seed |
| Rebel Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 25% QoQ, from 16 to 20 employees.
- Jul 26, 2026
Monthly visitors increased 36% MoM, reaching 2.1K.
Algen Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Algen Biotechnologies's valuation, stock price, and market status.
Is Algen Biotechnologies a public or private company?
Algen Biotechnologies is a private company.
What is the current stock price of Algen Biotechnologies?
Algen Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Algen Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Algen Biotechnologies worth (valuation)?
Valuation information for Algen Biotechnologies is not publicly available.
Can I buy Algen Biotechnologies stock?
Algen Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Algen Biotechnologies's last funding round?
Algen Biotechnologies's most recent funding round was Seed on August 31, 2021.
Who are the main investors in Algen Biotechnologies?
Key investors in Algen Biotechnologies include Cota Capital, Sequoia Capital, Viking Global Investors, Draper Associates, Y Combinator.
Will Algen Biotechnologies IPO soon?
No public IPO plans have been announced for Algen Biotechnologies.
How can I track Algen Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Algen Biotechnologies's shares on secondary markets.